Green Planet Bioengineering Co., Ltd. reported no operating revenues for the fiscal years ending December 31, 2025, and 2024, maintaining its status as a public reorganized shell corporation. The company incurred total expenses of $35,842 in 2025, a slight increase from $35,544 in 2024. The net loss for the year was $35,842, compared to a loss of $35,544 in the previous year, reflecting ongoing administrative costs primarily related to compliance and accounting. The company has not generated any revenue since its inception and continues to rely on funding from a related party, Global Funds Holdings Corp., to cover its operational expenses.
In terms of financial position, Green Planet's total liabilities increased to $500,976 as of December 31, 2025, up from $465,134 in 2024. This rise is attributed to an increase in accounts payable and amounts due to the related party, which reached $484,678 in 2025, compared to $459,634 in 2024. The company reported an accumulated deficit of $1,130,596 as of the end of 2025, up from $1,094,754 in 2024. The lack of cash or cash equivalents at year-end underscores the company's reliance on external funding for its survival.
Green Planet has not engaged in any significant strategic developments, such as acquisitions or product launches, during the reporting period. The company remains focused on identifying potential business opportunities for acquisition or merger, but it faces substantial risks and uncertainties regarding its ability to secure adequate financing. The management has indicated that the company's future operations depend heavily on finding profitable business opportunities and obtaining necessary funding, which may not materialize in the near term.
The company’s stock is quoted on the Over the Counter Bulletin Board under the symbol “GPLB.PK,” but there is currently no active trading market for its common stock. The company has not paid any dividends and does not anticipate doing so in the foreseeable future. The absence of a trading market and the lack of dividends may affect the liquidity and market value of its shares, which could further complicate the company's efforts to attract investors.
Looking ahead, Green Planet's management has expressed uncertainty regarding its ability to continue as a going concern, primarily due to its reliance on continued support from Global Funds and the need for additional financing. The company has indicated that it will continue to seek funding opportunities to execute its business plans, but there are no guarantees that such opportunities will be available. The financial statements have been prepared under the assumption that the company will continue as a going concern, but the ongoing lack of operational activity raises significant doubts about its future viability.
About Green Planet Bio Engineering Co. Ltd.
Green Planet Bioengineering Co., Ltd. is a shell company focused on acquiring or merging with existing businesses. Historically involved in agritech in China, it operates as a public reorganized shell with no current operations. Its primary value lies in its potential to facilitate future acquisitions, relying on external funding and business opportunities, with a focus on compliance and financial transparency.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.